{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:44Z","timestamp":1760189144561},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7237,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1989,7]]},"abstract":"<jats:p>A factor VIII (FVIII) concentrate, virus\u2010inactivated by the solvent\/detergent procedure, was studied in vitro. In contrast with most high\u2010purity, virus\u2010inactivated FVIII concentrates, it contains not only high levels of von Willebrand factor (vWF) antigen and ristocetin cofactor activity but also high molecular weight forms of von Willebrand factor. Furthermore, it is able to promote platelet adhesion on collagen in a perfusion system. In vivo studies performed in patients with different types of von Willebrand's disease provided evidence that this concentrate corrects Duke's bleeding time and prevents or stops haemorrhages. Thus, the particular advantages of this FVIII\/vWF preparation are safety, low content of contamination proteins, and efficacy in von Willebrand's disease.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1989.tb01244.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T14:22:19Z","timestamp":1279462939000},"page":"7-14","source":"Crossref","is-referenced-by-count":18,"title":["In vitro and in vivo characterization of a high\u2010purity, solvent\/detergent\u2010treated factor VIII concentrate: Evidence for its therapeutic efficacy in von Willebrand's disease"],"prefix":"10.1111","volume":"43","author":[{"given":"Claudine","family":"Mazurier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"De Romeuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armelle","family":"Parquet\u2010Gernez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Goudemand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00825.x"},{"key":"e_1_2_1_3_2","first-page":"753","article-title":"In vitro characterization of various factor VIII concentrates","volume":"37","author":"Yoshioka A","year":"1987","journal-title":"Arzneim Forsch Drug Res"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90374-4"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.236.24.2770"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320748"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1987.tb04892.x"},{"key":"e_1_2_1_8_2","first-page":"205","article-title":"Clinical and biological survey of haemophilia A and B patients infused with french heat\u2010treated concentrates","volume":"30","author":"Parquet\u2010Gernez A","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1984.tb00045.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25686071422.x"},{"key":"e_1_2_1_11_2","first-page":"293","volume-title":"Viral safety of solvent\/detergent treated FVIII concentrate","author":"Gazengel C","year":"1988"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92288-X"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0338-4535(83)80088-9"},{"key":"e_1_2_1_16_2","first-page":"205","article-title":"Nouvelle m\u00e9thode de diagnostic de l'h\u00e9mophilie. Dosage des facteurs antih\u00e9mophiliques A et B","volume":"24","author":"Soulier JP","year":"1953","journal-title":"Vox Sang"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1955.tb05484.x"},{"issue":"25","key":"e_1_2_1_18_2","first-page":"18","article-title":"Dosage de l'antig\u00e8ne li\u00e9 au facteur VIII par la technique ELISA. Int\u00e9r\u00eat dans l'\u00e9tude de la maladie de Willebrand","author":"Mazurier C","year":"1977","journal-title":"Path Biol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107465"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0038-1661448","article-title":"Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis","volume":"55","author":"Mazurier C","year":"1986","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_21_2","first-page":"522","article-title":"A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components","volume":"10","author":"Sakariassen KS","year":"1983","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_22_2","unstructured":"JorieuxS MazurierC DeRomeufC GoudemandM.Properties and interests of a monoclonal antibody to human von Willebrand factor (vWF). Proceedings of the Bari International Conference on Factor VIII\/von Willebrand factor Pizzomuno June 1015 1985."},{"issue":"40","key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0609.1984.tb02543.x","article-title":"Von Willebrand's disease from 1926\u20131983","author":"Nilsson IM.","year":"1984","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220311"},{"issue":"41","key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0609.1984.tb02773.x","article-title":"Principles of in vivo recovery and survival studies","author":"Allain JP.","year":"1984","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28588337344.x"},{"key":"e_1_2_1_27_2","first-page":"225","article-title":"Treatment of type III von Willebrands disease with solvent\/detergent\u2010treated factor III concentrates","volume":"30","author":"Gazengerl C","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V58.2.387.387","article-title":"Effect of multimeric structure of the factor VIII\/vWF protein on binding to platelets","volume":"58","author":"Gralnick HR","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.95.2.632"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V60.5.1132.1132","article-title":"Multimeric structure of platelet factor VIII\/von Willebrand factor: the presence of larger multimers and their reassociation with thrombin stimulated platelets","volume":"60","author":"Lopez\u2010Fernandez MF","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(83)90032-6"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood.V63.6.1291.1291","article-title":"Collagen\u2010factor VIII\/von Willebrand factor protein interaction","volume":"63","author":"Kessler CM","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1963.tb16528.x","article-title":"The effect of plasma and Cohn's fraction I of the Duke's and Ivy's bleeding times in von Willebrand's disease","volume":"17","author":"Borchgrevink CF","year":"1963","journal-title":"Acta Med Scand"},{"key":"e_1_2_1_34_2","first-page":"223","article-title":"The Duke and Ivy methods for determination of bleeding time","volume":"10","author":"Nilsson IM","year":"1963","journal-title":"Thromb Diath Haemorrh"},{"key":"e_1_2_1_35_2","first-page":"1251","article-title":"Effect of different FVIII\/vWF\u2010containing therapeutic products on platelet adhesion to collagen","volume":"58","author":"Romeuf C","year":"1987","journal-title":"Thromb Diath"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of Factor VIII\/von Willebrand factor following administration of DDVAP: implications for pathophysiology and therapy of von Willebrand's disease subtypes","volume":"59","author":"Ruggeri ZM","year":"1982","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1989.tb01244.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1989.tb01244.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:37:16Z","timestamp":1711633036000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1989.tb01244.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,7]]}},"alternative-id":["10.1111\/j.1600-0609.1989.tb01244.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1989.tb01244.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,7]]}}}